Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.00
Ask:
7.50
Spread: 1.50 (25.00%)
Market Cap: £15.95m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

AGM Statement

2 May 2014 10:00

RNS Number : 1690G
Symphony Environmental Tech. PLC
02 May 2014
Β 

ο»Ώ

2 May 2014

Β 

Β 

Symphony Environmental Technologies Plc

Β 

("Symphony" "Group" or the "Company")

Β 

AGM Statement

Β 

At the Annual General Meeting of the Company, held today, Nirj Deva DL, FRSA, MEP, Chairman of the Company, made the following statement:

Β 

On the 25 March 2014 we announced that in 2013 the Group saw a significant increase in revenues of 46% compared to 2012, resulting in a small EBITDA loss on recurring business of Β£10,000 for 2013. This compared extremely well with a Β£2 million EBITDA loss in 2012. The key factor is that the plastics division of the Company achieved an EBITDA profit of Β£220,000 in 2013 compared with a loss of Β£1.75 million the year before.

Β 

We also announced that with improved performance we continued to invest into broadening the product range for the three main sectors of our business, environmental (d2w), health and hygiene (d2p), and anti-counterfeiting (d2t). With our distribution network covering over 90 countries we are well placed to exploit the opportunities which we have created.

Β 

There were legislation changes that should positively impact on d2w revenues and we are also winning business on the basis of CSR values. Trials and negotiations continue to grow with our d2w d2p and d2t ranges, some of them with very large companies.

Β 

We also announced the commercialisation strategy for the tyre recycling division which continues to develop, with further announcements expected in the months to come.

Β Β Β 

We await regulatory approval for d2p in food packaging applications and we already have approvals for non food-packaging and other non food applications.

Β 

I am also pleased to advise that the management team and the technical team are developing exciting new formulations and IP with a focus on expanding the product range into agricultural, retail and chemical sectors.

Β 

In the 25th March announcement we advised of a new contract award from a major supermarket group for d2w, and that sales volumes were expected to be significant, but not verified, and with deliveries expected to commence in April. I am pleased to confirm that deliveries have started with the expectation of a full roll-out in the second half.

Β 

Since my last announcement, I am pleased to confirm that we have signed a product development agreement with a world leading brand, and are in negotiations with others for d2w and d2p. In addition, we have completed successful trials on new applications for the d2w and d2p technologies.

Β 

We look forward to a successful year ahead.

Β 

Β 

Β 

Β 

Β 

- Ends -

Β 

Contacts

Symphony Environmental Technologies Plc

Β 

Michael Laurier, CEO

Tel: +44 (0) 20 8207 5900

Ian Bristow, FD

Β 

Β 

Cantor Fitzgerald Europe

Β 

Mark Percy (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Paul Jewell (Corporate Broking)

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMSSWSWEFLSEFI
Date   Source Headline
25th Mar 20243:02 pmRNSReplacement - Subscription and Notice of GM
22nd Mar 20247:01 amRNSPrimaryBid Offer
22nd Mar 20247:00 amRNSSubscription, PrimaryBid Offer and Notice of GM
14th Mar 20247:00 amRNSExtension to Convertible Loan Agreements
13th Mar 20247:00 amRNSUS Environmental Protection Agency positive report
9th Feb 20247:59 amRNSEU Judgment – Company Response
31st Jan 20249:48 amRNSEU Court Judgement
18th Jan 20247:00 amRNSTrading Update and EU Case
8th Jan 20247:00 amRNSGrant of options and PDMR dealing
2nd Jan 20247:00 amRNSDirector appointment & grant of options
28th Dec 20237:00 amRNSOptions amendments
18th Oct 20232:10 pmRNS£1.0m convertible loan agreement
29th Sep 20237:00 amRNSInterim Results
26th Sep 20237:00 amRNSYemen Enforces Oxo-Biodegradable Plastic Law
11th Aug 20237:00 amRNSDirectorate Change
1st Aug 20237:00 amRNSPre-close Trading Update
4th Jul 20237:00 amRNSDirectorate Change
29th Jun 20231:46 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
7th Jun 20238:34 amRNSPosting of Annual Report & Accounts & AGM Notice
30th May 20237:00 amRNSPreliminary Results
21st Mar 20237:00 amRNSEU court hearing
13th Mar 20233:40 pmRNSConvertible loan agreement & revenue update
9th Mar 20237:00 amRNSd2w BioBottles supply agreement with TricorBraun
23rd Dec 20227:00 amRNSTrading update
31st Oct 20227:00 amRNSAttendance at world’s leading plastics trade fair
28th Oct 20222:51 pmRNSDirector/PDMR Shareholdings – Option amendments
29th Sep 20229:00 amRNSInvestor Presentation
29th Sep 20227:01 amRNSSymphony India operations update
29th Sep 20227:00 amRNSInterim results for the 6 m/e 30 June 2022
9th Aug 20227:00 amRNSMexican Technical Standard Validating d2w
8th Aug 20227:00 amRNSAgreement for Middle East manufacturing
1st Aug 20227:01 amRNSEquity subscription and grant of warrants
1st Aug 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSd2p Anti-Insect Sales
29th Jun 20222:00 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
28th Jun 20227:00 amRNSd2p Supply Agreement with Grupo Bimbo
27th Jun 20227:00 amRNSPeru legal action outcome
7th Jun 20227:00 amRNSPosting of Annual Report and Notice of AGM
18th May 20227:00 amRNSAppointment of Executive Director
4th May 20227:00 amRNSGrant of Options
20th Apr 20227:00 amRNSSymphony India Sustainability Award
30th Mar 20227:00 amRNSPreliminary results
24th Feb 20223:49 pmRNSExtension of options
23rd Feb 20227:00 amRNSNew US Supply Contract
17th Dec 20212:09 pmRNSTrading and business update
29th Nov 20217:00 amRNSPositive DEFRA consultation
19th Nov 20212:54 pmRNSDirector/PDMR Shareholding - options amendment
19th Nov 20212:11 pmRNSDirector/PDMR Shareholding - option amendments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.